Gilead Sciences, INC. (GILD) — SC 13D/A Filings

All SC 13D/A filings from Gilead Sciences, INC.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (3)

Gilead Sciences Files SC 13D/A for Assembly Biosciences — Jun 20, 2024 Risk: medium
On June 20, 2024, Gilead Sciences, Inc. filed an amendment to its Schedule 13D concerning Assembly Biosciences, Inc. This filing indicates a change in beneficia
Gilead Sciences Files SC 13D/A Amendment for Galapagos NV — May 2, 2024 Risk: medium
Gilead Sciences, Inc. filed an amendment (No. 3) to its Schedule 13D on April 30, 2024, regarding its holdings in Galapagos NV. The filing indicates a change in
Gilead Amends Arcus Biosciences Stake, Signals Ownership Change — Jan 31, 2024
Gilead Sciences, Inc. filed an amended Schedule 13D on January 31, 2024, updating its beneficial ownership in Arcus Biosciences, Inc. This amendment, triggered

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX